Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP27X inhibits BCL2L11. 3 / 3

| 3

➶

reach

"Cathepsin K inhibition induced mitochondrial ROS enhances sensitivity of cancer cells to anti-cancer drugs through USP27x mediated Bim protein stabilization."

31901727

➶

reach

"Loss of endogenous Usp27x enhances the Bim degrading activity of oncogenic Raf."

27013495

➶

reach

"USP27x DUB antagonizes the Raf-ERK Bim degradation pathway thus stabilizing Bim expression."

29479529

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

USP27X inhibits BCL2L11. 3 / 3

Our Sources:

Databases

Reading